Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation.

Notohamiprodjo M, Djafarzadeh R, Mojaat A, von Lüttichau I, Gröne HJ, Nelson PJ.

Protein Eng Des Sel. 2006 Jan;19(1):27-35. Epub 2005 Oct 26.

PMID:
16251221
2.

Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities.

Djafarzadeh R, Mojaat A, Vicente AB, von Lüttichau I, Nelson PJ.

Biol Chem. 2004 Jul;385(7):655-63.

PMID:
15318815
3.

Identification of a signal transduction pathway that regulates MMP-9 mRNA expression in glomerular injury.

von Lüttichau I, Djafarzadeh R, Henger A, Cohen CD, Mojaat A, Jochum M, Ries C, Nelson PJ, Kretzler M.

Biol Chem. 2002 Jul-Aug;383(7-8):1271-5.

PMID:
12437116
4.

Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells.

Fessele S, Boehlk S, Mojaat A, Miyamoto NG, Werner T, Nelson EL, Schlondorff D, Nelson PJ.

FASEB J. 2001 Mar;15(3):577-9. Epub 2001 Jan 5.

PMID:
11259372
5.

ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells.

Boehlk S, Fessele S, Mojaat A, Miyamoto NG, Werner T, Nelson EL, Schlöndorff D, Nelson PJ.

Eur J Immunol. 2000 Apr;30(4):1102-12.

Supplemental Content

Loading ...
Support Center